Common use of Press Releases and Similar Information Clause in Contracts

Press Releases and Similar Information. The Company and Cellectis will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Group and to comment thereon. Cellectis and the Company will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Company shall coordinate the timing of its respective earnings release conference calls with Cellectis earning calls timing, such that the Company shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings release, provided that Cellectis will inform the Company of its next financial year agenda quarterly releases not later than December 15 of the preceding year. No later than eight hours prior to the time and date that a Party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party will deliver to the other Party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Party’s Group to employees of any member of that Party’s Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party will consult with the other Party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party will deliver to the other Party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company shall consult with Cellectis prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto.

Press Releases and Similar Information. The Company and Cellectis Pfizer will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Group and to comment thereon. Cellectis Pfizer and the Company will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Pfizer and the Company shall coordinate the timing of its their respective earnings release conference calls with Cellectis earning calls timing, such that the Company shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings release, provided that Cellectis will inform the Company be permitted to hold such calls prior to those of its next financial year agenda quarterly releases not later than December 15 of the preceding yearPfizer. No later than eight (8) hours prior to the time and date that a Party party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party party will deliver to the other Party party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Partyparty’s Group to employees of any member of that Partyparty’s Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party party will consult with the other Party party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party party will deliver to the other Party party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company shall consult with Cellectis Pfizer prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date Transactions or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto.

Press Releases and Similar Information. The Company Venator and Cellectis Huntsman will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Venator Group and to comment thereon. Cellectis Huntsman and the Company Venator will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Company Huntsman and Venator shall coordinate the timing of its their respective earnings release conference calls with Cellectis earning calls timing, such that the Company Venator shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings release, provided that Cellectis will inform the Company be permitted to hold such calls prior to those of its next financial year agenda quarterly releases not later than December 15 of the preceding yearHuntsman. No later than eight (8) hours prior to the time and date that a Party party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party party will deliver to the other Party party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Partyparty’s Group to employees of any member of that Partyparty’s Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Venator Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party party will consult with the other Party party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party party will deliver to the other Party party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company Venator shall consult with Cellectis Huntsman prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date Transactions or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto.

Press Releases and Similar Information. The Company and Cellectis Pfizer will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Group and to comment thereon. Cellectis Pfizer and the Company will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Pfizer and the Company shall coordinate the timing of its their respective earnings release conference calls with Cellectis earning calls timing, such that the Company shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings release, provided that Cellectis will inform the Company be permitted to hold such calls prior to those of its next financial year agenda quarterly releases not later than December 15 of the preceding yearPfizer. No later than eight (8) hours prior to the time and date that a Party party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party party will deliver to the other Party party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Party’s party's Group to employees of any member of that Party’s party's Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party party will consult with the other Party party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party party will deliver to the other Party party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company shall consult with Cellectis Pfizer prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date Transactions or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto. This Section 7.01(k) shall not apply with respect to Pfizer's 2012 earnings release or Pfizer's 2013 interim financial guidance.

Press Releases and Similar Information. The Company and Cellectis will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Group and to comment thereon. Cellectis and the Company will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Company shall coordinate the timing of its respective earnings release conference calls with Cellectis earning calls timing, such that the Company shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings earning release, provided that Cellectis will inform the Company of its next financial year agenda quarterly releases not later than December 15 of the preceding year. No later than eight hours prior to the time and date that a Party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party will deliver to the other Party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Party’s Group to employees of any member of that Party’s Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party will consult with the other Party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party will deliver to the other Party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company shall consult with Cellectis prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto.

Press Releases and Similar Information. The Company and Cellectis Pfizer will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Group and to comment thereon. Cellectis Pfizer and the Company will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Pfizer and the Company shall coordinate the timing of its their respective earnings release conference calls with Cellectis earning calls timing, such that the Company shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings release, provided that Cellectis will inform the Company be permitted to hold such calls prior to those of its next financial year agenda quarterly releases not later than December 15 of the preceding yearPfizer. No later than eight (8) hours prior to the time and date that a Party party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party party will deliver to the other Party party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Partyparty’s Group to employees of any member of that Partyparty’s Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party party will consult with the other Party party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party party will deliver to the other Party party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company shall consult with Cellectis Pfizer prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date Transactions or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto. This Section 7.01(k) shall not apply with respect to Pfizer’s 2012 earnings release or Pfizer’s 2013 interim financial guidance.

Press Releases and Similar Information. The Company Venator and Cellectis Huntsman will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Venator Group and to comment thereon. Cellectis Huntsman and the Company Venator will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Company Huntsman and Venator shall coordinate the timing of its their respective earnings release conference calls with Cellectis earning calls timing, such that the Company Venator shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings release, provided that Cellectis will inform the Company be permitted to hold such calls prior to those of its next financial year agenda quarterly releases not later than December 15 of the preceding yearHuntsman. No later than eight hours one (1) day prior to the time and date that a Party party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party party will deliver to the other Party party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Partyparty’s Group to employees of any member of that Party’s Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Venator Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party party will consult with the other Party party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party party will deliver to the other Party party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company Venator shall consult with Cellectis Huntsman prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date Transactions or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto.

Press Releases and Similar Information. The Company From and Cellectis will after the IPO Effective Date, Nextracker PubCo and Flex shall consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will shall give each other the opportunity to review the information therein relating to the Company Nextracker Group and to comment thereon. Cellectis From and after the Company will make reasonable efforts to issue their respective annual IPO Effective Date, Flex and quarterly earnings releases at approximately the same time on the same date. Company Nextracker PubCo shall coordinate the timing of its (i) their respective earnings release conference calls with Cellectis earning calls timing, such that the Company shall issue its annual calls; and quarterly (ii) their respective public earnings release no later than five days before issuance and filings with the Cellectis’ annual and quarterly earnings releaseCommission, provided that Cellectis will inform the Company of its next financial year agenda quarterly releases not later than December 15 of the preceding yearin each case as directed by Flex. No later than eight hours one Business Day prior to the time and date that a Party Nextracker PubCo intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party will Nextracker PubCo shall deliver to the other Party Flex copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Party’s Group to employees of any member of that Party’s the Nextracker Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Group membermember of the Nextracker Group. In addition, from and after the IPO Effective Date, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentencessentence, the issuing Party will shall consult with the other Party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately , and immediately following the issuance thereof, the issuing Party will shall deliver to the other Party copies of final drafts of all press releases and other public statements. Prior to The Nextracker Group shall obtain the Effective Date, the Company shall consult with Cellectis written consent of Flex prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date Transactions or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority Entity with respect thereto, other than, in each case, with respect to disclosures made that are substantially consistent with disclosure contained in any IPO Disclosure.

Press Releases and Similar Information. The Company Venator and Cellectis Huntsman will consult with each other as to the timing of their annual and quarterly earnings releases and any interim financial guidance for a current or future period and will give each other the opportunity to review the information therein relating to the Company Venator Group and to comment thereon. Cellectis Huntsman and the Company Venator will make reasonable efforts to issue their respective annual and quarterly earnings releases at approximately the same time on the same date. Company Huntsman and Venator shall coordinate the timing of its their respective earnings release conference calls with Cellectis earning calls timing, such that the Company Venator shall issue its annual and quarterly earnings release no later than five days before the Cellectis’ annual and quarterly earnings release, provided that Cellectis will inform the Company be permitted to hold such calls prior to those of its next financial year agenda quarterly releases not later than December 15 of the preceding yearHuntsman. No later than eight (8) hours prior to the time and date that a Party party intends to publish its regular annual or quarterly earnings release or any financial guidance for a current or future period, such Party party will deliver to the other Party party copies of substantially final drafts of all related press releases and other statements to be made available by any member of that Partyparty’s Group to employees of any member of that Partyparty’s Group or to the public concerning any matters that could be reasonably likely to have a material financial impact on the earnings, results of operations, financial condition or prospects of any Company Venator Group member. In addition, prior to the issuance of any such press release or public statement that meets the criteria set forth in the preceding two sentences, the issuing Party party will consult with the other Party party regarding any changes (other than typographical or other similar minor changes) to such substantially final drafts. Immediately following the issuance thereof, the issuing Party party will deliver to the other Party party copies of final drafts of all press releases and other public statements. Prior to the Effective Date, the Company Venator shall consult with Cellectis Huntsman prior to issuing any press releases or otherwise making public statements with respect to the IPO and transactions contemplated by this Agreement and the Ancillary Agreements following the Effective Date [Transactions] or any of the other transactions contemplated hereby and prior to making any filings with any Governmental Authority with respect thereto.